Právní předpis byl sestaven k datu 25.10.2026.
Zobrazené znění právního předpisu je účinné od 01.01.2026.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek proti pneumokokovým infekcím pro očkování pojištěnců nad 65 let věku
529/2025 Sb.
529
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 10. prosince 2025
x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx proti xxxxxxxxxxxxx xxxxxxxx pro xxxxxxxx xxxxxxxxxx nad 65 xxx xxxx
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §30 xxxx. 2 písm. f) xxxxxx č. 48/1997 Xx., x xxxxxxxx xxxxxxxxxx xxxxxxxxx x x xxxxx x xxxxxxxx některých xxxxxxxxxxxxx xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xxxxxxxxx složení xxxxxxxx xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx pro xxxxxxxx xxxxxxxxxx xxx 65 xxx xxxx:
1) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxxxxxxxx xxxxxxxx
Xxxxx dávka (0,5 xx) obsahuje:
Polysacharid xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 11,2 2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 31,2&xxxx;2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 41,2 2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx sérotypu 51,2&xxxx;2,2 xxxxxxxxxx
xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 6X1,2&xxxx;2,2 mikrogramů
polysacharid bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 6B1,2 4,4 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 7F1,2 2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 81,2&xxxx;2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 9X1,2&xxxx;2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 10A1,2 2,2 xxxxxxxxxx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 11X1,2&xxxx;2,2 mikrogramů
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 12X1,2&xxxx;2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 141,2 2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae sérotypu 15X1,2&xxxx;2,2 xxxxxxxxxx
xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 18X1,2&xxxx;2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 19A1,2 2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X1,2&xxxx;2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 22X1,2&xxxx;2,2 xxxxxxxxxx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 23F1,2 2,2 xxxxxxxxxx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 33X1,2&xxxx;2,2 xxxxxxxxxx
1&xxxx;Xxxxxxxxxx x xxxxxx proteinem CRM197 (přibližně 51 µg xx xxxxx).
2&xxxx;Xxxxxxxxxx xx fosforečnan xxxxxxx (0,125 xx xxxxxxx xx dávku).
NEBO
2) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxxxxxxxx xxxxxxxx
1 xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae sérotypu 31&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 6A1 4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 7F1 4 μx
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 81&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 9X1&xxxx;4 μg
Polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 10A1 4 μx
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 11X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus pneumoniae xxxxxxxx 12X1&xxxx;4 μg
Polysacharid xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx sérotypu 15A1 4 μx
Xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx x xxXXx15X (xx-X-xxxxxxxxxxx xxxxxxx 15X)1 4 μg
Polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 16F1 4 μx
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx pneumoniae sérotypu 17X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19A1 4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx sérotypu 20X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 22X1&xxxx;4 μg
Polysacharid bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 23X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 23B1 4 μx
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 24X1&xxxx;4 μg
Polysacharid bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 311&xxxx;4 μg
Polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 33F1 4 μx
Xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 35X1&xxxx;4 μg
1 Konjugován x xxxxxxxxxxx xxxxxxx XXX197. XXX197&xxxx;xx netoxický xxxxxx xxxxxxxxxxxx xxxxxx (xxxxxxxxxxxxx x bakterie Corynebacterium xxxxxxxxxxx C7) xxxxxxxxxxxxx xxxxxxxxxxx x bakterii Xxxxxxxxxxx fluorescens.
Sdělení Xxxxxxxxxxxx xxxxxxxxxxxxx č. 118/2024 Sb., x xxxxxxxxxx xxxxxxx očkovacích xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx pro očkování xxxxxxxxxx xxx 65 xxx věku, xx xxxxxxx.
Xxxx xxxxxxx nabývá xxxxxxxxx dnem 1. xxxxx 2026.
Ministr:
prof. XXXx. Xxxxx, CSc., MBA, XXXX, v. x.
Informace
Právní předpis x. 529/2025 Xx. xxxxx xxxxxxxxx xxxx 1.1.2026.
Xx xxx xxxxxxxx nebyl xxxxx či xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx právních xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx xxxxxxxx.